Intelligence Feed event · Equity · 2026-09-27

    Staar Surgical Board Authorizes $50 Million Share Repurchase Program

    Question

    Staar Surgical Board Authorizes $50 Million Share Repurchase Program

    Direct answer

    Staar Surgical (STAA) authorized a $50 million share buyback program, driving a 7.5% single-session gain. The medical device manufacturer's board pointed to ample free cash flow and balance sheet cash reserves as the justification for capital returns. The move reflects increasing corporate appetite among mid-cap medical technology names to utilize share repurchases to defend valuations against market volatility.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-27
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Staar Surgical Board Authorizes $50 Million Share Repurchase Program”, revision 1, evidence through 2026-09-27. https://marketontology.com/market-events/2026-09-27/staar-surgical-board-authorizes-50-million-share-repurchase-program-e82982

    EQUITY
    Staar Surgical Board Authorizes $50 Million Share Repurchase Program
    Staar Surgical (STAA) authorized a $50 million share buyback program, driving a 7.5% single-session gain. The medical device manufacturer's board pointed to ample free cash flow and balance sheet cash reserves as the justification for capital returns. The move reflects increasing corporate appetite among mid-cap medical technology names to utilize share repurchases to defend valuations against market volatility.
    STAA
    Impact
    62
    SEP 27
    SIG
    90%
    STAA
    Staar Surgical Board Authorizes $50 Million Share Repurchase Program
    Staar Surgical (STAA) authorized a $50 million share buyback program, driving a 7.5% single-session gain. The medical device manufacturer's board pointed to ample free cash flow and balance sheet cash reserves as the justification for capital returns. The move reflects increasing corporate appetite among mid-cap medical technology names to utilize share repurchases to defend valuations against market volatility.
    → Execution of the $50 million repurchase reduces outstanding float, directly increasing earnings per share accretion.
    Impact
    Staar Surgical (STAA) authorized a $50 million share buyback program, driving a 7.5% single-session gain. The medical device manufacturer's board pointed to ample free cash flow and balance sheet cash reserves as the justification for capital returns. The move reflects increasing corporate appetite among mid-cap medical technology names to utilize share repurchases to defend valuations against market volatility.
    Affected
    STAA
    Transmission
    Execution of the $50 million repurchase reduces outstanding float, directly increasing earnings per share accretion.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    STAAUpagreed20.51 2026-09-25+1.76%+9.56%Pending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month